According to the latest report from WHO, the incidence of cardiovascular diseases has recently increased globally. Every year in the world, on average, about 17.5 million people die from cardiovascular-related causes, of which acute myocardial infarction is one of the leading factors that endanger patients' lives. For early diagnosis of the disease, the H-FABP cardiac enzyme index is a new and highly accurate work.

Myoglobin test is one of the useful and highly effective myocardial infarction tests to promptly detect the symptoms of the disease, thereby helping doctors to have appropriate treatment or prevention methods. So what is the myoglobin test in myocardial infarction and how is it done?

CKMB test is one of the biochemical tests for early diagnosis of acute myocardial infarction. Clinicians consider the CKMB index to have a relatively high specificity for the disease compared with many other plasma enzymes such as troponin or myoglobin. However, this test can still give a false-positive result in many cases.